← Back to headlines
Wegovy and Ozempic owner dealt blow as next-gen weight-loss drug is labelled ‘obsolete’
Novo Nordisk’s shares fall sharply after testing of CagriSema falls short of investors’ expectations
23 Feb, 14:26 — 23 Feb, 14:26
Sources
Showing 1 of 1 sources
Related Stories
Irish Health Agency Fined €645,000 for Storing Records in Derelict Sites
1h ago
New Urine Test Detects Over 90 Percent of Bladder Cancer Cases
2h ago
Swimmer Hospitalized Following Suspected Shark Attack in Massachusetts
5h ago
Wellington Clinics Suspends Kidney Transplants Amid Organ Harvesting Probe
11h ago